IMFINZI-subQ
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
Astellas Pharma Inc
National Cancer Institute (NCI)
Exscientia AI Limited
Seagen Inc.
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Radiopharm Theranostics, Ltd
National Cancer Institute (NCI)
PMV Pharmaceuticals, Inc
NeoImmuneTech
BeOne Medicines
Neonc Technologies, Inc.
Tasca Therapeutics
NiKang Therapeutics, Inc.
MacroGenics
MacroGenics
AstraZeneca
SystImmune Inc.
SN BioScience
ImmunityBio, Inc.
VM Oncology, LLC
GV20 Therapeutics
DualityBio Inc.
Incyte Corporation
Janux Therapeutics
NiKang Therapeutics, Inc.
Novelty Nobility, Inc.
Merck Sharp & Dohme LLC
Pfizer
Hoffmann-La Roche
Incyte Corporation
University of Virginia
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Marengo Therapeutics, Inc.
Shanghai Public Health Clinical Center
TransThera Sciences (Nanjing), Inc.
NRG Oncology
OncoC4, Inc.
Hutchmed
SOLTI Breast Cancer Research Group
Stanford University
Seagen Inc.
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.